That was an oblique reference to Roche's $3 billion blockbuster Hemlibra (emicizumab), which can be taken as infrequently as once per month in some patients, although others may require weekly or ...

Sanofi and Sobi's haemophilia partnership has been under competitive pressure from new therapies like Roche's antibody Hemlibra, so the two companies are hoping a new long-acting drug candidate ...